Trending
- Targeted Agents, Amyloidosis, and Defining a Cure in Plasma Cell Disorders
- How Can Literature and Peer Review Impact an Oncology Fellow’s Career?
- Joint Use of Rabbit ATG and poSt-tranSplant Immunosuppression with Cyclophosphamide, without any other graft-versus-host disease prophylaxis, for HLA-matched peripheral blood hematopoietic cell transplantation – The JURASSIC phase I trial
- Switching to SC Dosing and Considering PRO Data for Amivantamab in NSCLC
- Isatuximab Combo Increases MRD Negativity in MRD-Positive Multiple Myeloma
- Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
- Validating a linked primary–secondary care data platform for analysis of non-specific cancer symptom pathways: a retrospective study
- CRISPR could help doctors attack blood cancer without destroying healthy cells
Friday, September 25